79380032 - NORDICPRO-C6

Information

  • Trademark
  • 79380032
  • Serial Number
    79380032
  • Filing Date
    July 19, 2023
    a year ago
  • Transaction Date
    November 06, 2024
    a month ago
  • Status Date
    November 05, 2024
    a month ago
  • Location Date
    November 05, 2024
    a month ago
  • Status Code
    661
  • Current Location
    TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    BIBB, SCOTT
  • Attorney Docket Number
    1478.0004
    Attorney Name
    Andrew M. Smith
    Law Office Assigned Location Code
    L90
  • Owners
Mark Drawing Code
4
Mark Identification
NORDICPRO-C6
Case File Statements
  • GS0051: diagnostic biomarker reagents for medical and clinical purposes; diagnostic biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; medical diagnostic biomarker assays to quantify disease activity; medical diagnostic biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; medical diagnostic test strips for research and diagnostic use for protein fragment detection, disease detection, disease analysis and quantifying disease activity; diagnostic preparations for medical purposes; diagnostic agents for medical use
  • PM0001: NORDIC PRO C SIX
  • GS0421: custom design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; custom design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; custom design and development of biochemical, pharmaceutical, and medical assays; custom design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; providing scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; medical and scientific research, namely, identification of predictive and prognostic biomarkers for clinical trials; medical and scientific research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services for clinical trials; scientific research in the nature of conducting clinical trials for others; biological research and analysis, namely, analysis of pharmacodynamic data; biological research and analysis, namely, analysis of data relating to biomarkers; development services in the field of diagnostic preparations, equipment and tests; medical and scientific research, namely, conducting clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes namely diagnostic testing services; medical research laboratory services; research laboratory services in the fields of medical and pharmaceutical research; advice, information and assistance relating to the foregoing
Case File Event Statements
  • 10/5/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 10/6/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/10/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/25/2024 - 9 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/2/2024 - 7 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/3/2024 - 7 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 5/8/2024 - 7 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/8/2024 - 7 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/27/2024 - 7 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/5/2024 - a month ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/5/2024 - a month ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/5/2024 - a month ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA